next generation sequencing applications
play

Next Generation Sequencing Applications Wilfred van IJcken Erasmus - PowerPoint PPT Presentation

Center for Biomics Next Generation Sequencing Applications Wilfred van IJcken Erasmus MC Center for Biomics Biomedical Research Techniques (XVIth ed.), Nov 6 Learning objectives Previous presentation NGS: The basics Background


  1. Center for Biomics Next Generation Sequencing Applications Wilfred van IJcken Erasmus MC Center for Biomics Biomedical Research Techniques (XVIth ed.), Nov 6

  2. Learning objectives Previous presentation NGS: The basics  Background  Illumina sequencing technology  Terminology This presentation  Research applications  Diagnostic applications  Target enrichment  Future directions

  3. Overview Sequencing Preparation Methods RNA transcription RNA structure RNA low level DNA low level DNA rearrangements Methylation DNA-protein interactions http://res.illumina.com/documents/applications/sequencing-technology-poster.pdf

  4. NGS Applications Gene expression analysis Discovery of novel transcripts, splice variants, miRNAs Protein-DNA/RNA interactions (ChIPSeq) genomic DNA interactions (3C, 4C, 5C Seq) Epigenetic profiling (DNA methylation) Targeted DNA sequencing Exome Sequencing Whole genome re-sequencing and De novo

  5. ChIP-Seq Detect protein-DNA interactions:

  6. Chip-Seq Peak detection Binding motifs Gata1 Gata1 only peaks Ldb1 Transcription Factors Tal1 Ldb1/Gata1/Tal1/ Eto2/Mtgr1 peaks Eto2 p300 Chromatin modifiers LSD1 Structural proteins CTCF Soler, van IJcken et al , Genes and Dev. 2010 Soler, van IJcken et al , Methods 2010

  7. 3C-Seq Detect DNA-DNA interactions close in 3D Stadhouders, ..,van IJcken et al .

  8. Epigenetic profiling (methylation) Cytosine methylation (5-mC) has significant effect on gene expression and chromatin remodeling Techniques: WGBS-Seq C to U with sodium bisulphite 5-mC stays C RRBS-Seq MspI digestion MeDIP Anti-5-mC antibody MIRA Capture with GST labeled protein Or 450k array e.g. Carvalho, van IJcken et al. Epigenetics and chromatin 2012 doi:10.1186/1756-8935-5-9

  9. Targetted sequencing Custom or predefined probes

  10. How does targetted sequencing result look?

  11. Zoom in sequence result

  12. Variation is not only SNP Structural variants (SVs), Short InDels SNPs [e.g. kb-Mb-sized deletions, insertions, inversions, fusion genes] GATTTAGATCGCGATAGAG GATT------------GAG GATTTAGATCTCGATAGAG GATTTAGATCTCGATAGAG More difficult to detect than SNPs ~0.1% of the genomes of any presumably >0.1% of the genome two individuals differ due to SNPs

  13. Example: Targetted sequencing  H ypertrophic C ardio M yopathy  prevalence 1 : 500  Main cause of sudden cardiac dead  50 gene panel  Mybpc3, myh7 etc…  10 patients (multiplexed)  indexing Bait design; Agilent Sureselect; ~50 genes, ~800 exons  1 MiSeq run PE 150 bp  Alignment, Variant calling  Clinical report  Validation sanger sequencing of 10 mutations including indel

  14. Targeted panel results Cardiomyopathy Old New Patient benefits Sanger Sequencing NGS 1. Diagnostic yield ↑ 33% 2. Turn around time ↓ 6 to 2 months 3. New type variants detected (indels + somatic mosaicisms) 2 genes 48 genes

  15. Exome sequencing Exome = all coding regions (~ exons) of genome

  16. > 200 Disease genes uncovered by Exome sequencing Neonatal Diabetes Mellitus – France – 2010 Miller syndrome – USA - 2009 o o Autoimmune lymphoproliferative syndrome – TARP syndrome – USA - 2010 o o USA – 2010 Schinzel-Giedion syndrome - o Familial Amyotrophic lateral sclerosis – USA – Netherlands - 2010 o 2010 Fowler Syndrome – Canada - 2010 o Non-syndromic mental retardation – USA – 2010 Terminal Osseous Dysplasia – o o Osteogenesis Imperfecta – Netherlands – 2010 o Germany/Netherlands – 2011 Hearing Loss – USA – 2010 o Hajdu-Cheney syndrome – London /France– Perrault Syndrome – USA – 2010 o o 2011 Kaposi sarcoma – USA – 2010 o Acne Inversa – China – 2011 Sensenbrenner Syndrome – o o Leucoencephalopathy – Japan – 2011 Netherlands – 2010 o Taybi-Linder syndrome – France – 2011 Hyperphosphatasia syndrome – o o Ochoa syndrome – Saudi Arabia – 2011 Germany – 2010 o Spastic paraparesis - USA – 2011 Kabuki syndrome - USA – 2010 o o Distal Arthrogryposis – USA – 2011 Van Den Ende-Gupta syndrome – o o Amelogenesis Imperfecta – UK - 2011 Canada – 2010 o

  17. Whole genome sequencing Human and other species Genome sequenced 2007 Craig Venter 7,5x 2008 James Watson 7,4x 2008 Han Chinese 36x 2008 Yorubian (nigeria) 30x 2008 Leukemia patient T/N 33x (14x) 2009 Seong Kim (korean) 29x 2014 100k genomes projects Identify variation between individuals

  18. Whole genome sequencing X Ten Outsource ? $1000 genome $1000 genome 30x 40x

  19. Human and disease, what to sequence? • Most mendelian diseases are caused by exome mutations • Exome is only ~1.6 % of human genome (50Mbp) Panel Exome Whole genome Genome >0,01% 1,6 % 95 % Sequencing 1/400x 1x 60x Interpretation ++ + + / - Validation ++ + + / - Speed ++ + - Cost (est.) € 500 € 1000 € 5000

  20. Comparision of exome and genome sequencing

  21. Non invasive trisomy testing (NIPT) 10 weeks pregnancy 5% fetal DNA DNA isolation Prepare NGS Analysis Trisomy Report

  22. NIPT: determine fetal chromosomal copy number Fetal cfDNA Maternal cfDNA Chr 21 Chr 21 Euploid Fetal Pregnancy Trisomy

  23. NIPT in the news

  24. Diagnostic applications  Targetted sequencing Cardio Myopathies, Ciliopathies, Cancer hotspot panel, Noonan, Neurodegenerative diseases, …  Exome sequencing Unknown disease, de novo  Whole genome sequencing Unknown disease, non-exonic  Non invasive diagnostics prenatal plasma T21 testing  Cancer sequencing germline mutations, therapy  HLA typing transplantation

  25. Personalized medicine me Doctor here is my genome and variation  we need cheaper and faster High throughput sequencing  we need educated doctors / clinicians

  26. Future • Technical challenges resolved • Implementation in tumor sequencing (free circulating tumor DNA) • Inplementation in new born screening • Replaces (partly) Sanger sequencing • Interpretation challenge • Ethical, legal, social issues • Education doctors / clinicians • Choice between panel, exome, whole genome • Faster diagnosis (1 week from sample to diagnosis)

  27. MinION  USB sized sequencer  One time use  $ 900 dollar  500 nanopores  >100 Mbp / h  User defined runtime  Lifetime electrodes is limiting (days) No sample prep Measure directly from blood

  28. Erasmus Center for Biomics Genomics core facility at ErasmusMC www.biomics.nl w.vanijcken@erasmusmc.nl LNA

Recommend


More recommend